Skip to main content

OSSTEC

ApplicationLondon, United KingdomFounded 2021· One of 462 Application companies tracked by AMPulse

3D printed bone-like titanium implants for joint replacement enabling faster recovery

CEO / Founder
Dr. Maxwell Munford
Team Size
11-50
Stage
Active
Total Funding
$4.7M
Latest Round
Series A
Key Investors
Empirical Ventures, SFC Capital, Oxford Innovation Finance, Parkwalk Advisors, Embryo Ventures, Imperial College Enterprise Fund

Technology & Products

Key Products

ASCENT™ 3D printed unicondylar (partial) knee with biomimetic cementless fixation; CLARITY™ instrumentation

Technological Advantage

Patented 3D printing technology from 10 years Imperial College research mimicking cartilage and bone structures

Differentiation

Value Proposition

Cementless 3D printed lattice implants enabling same-day discharge without bone cement complications

How They Differentiate

Bone-like lattice structure vs solid metal implants, enabling cementless fixation

Market & Competition

Target Customers

Orthopedic surgeons, hospitals, outpatient surgery centers

Industry Verticals

Orthopedics, Medical Devices, Joint Replacement, Healthcare

Competitors

Stryker, Zimmer Biomet, Smith & Nephew

Growth & Milestones

Growth Metrics

CEO nominated for Entrepreneur of the Year

Major Milestones

Spinout from Imperial College PhD (2021), £1.2M Seed (2023), £2.5M Series A led by Empirical Ventures (2025)

Notable Customers

UK healthcare system (targeted)